Malaria infection in humans, caused by unicellular parasites from the genus Plasmodium and transmitted via the bite of an infected Anopheles mosquito, is a major global health challenge. Researchers are actively...
Malaria is one of the most important public health concerns in the world. According to the latest WHO World Malaria Report, there were 247 million cases of malaria in 2021 compared to 245 million cases in 2020. The...
A three-dose regimen of a whole-parasite vaccine against malaria – called Plasmodium falciparum sporozoite (PfSPZ) vaccine – demonstrated safety and efficacy when tested in adults living in Burkina Faso, West Africa...
A new R21/Matrix-M malaria vaccine shows 75% efficacy in a Phase2b trial – a potentially game-changing result compared to the WHO-approved RTS,S/AS01 (RTS,S) vaccine. The WHO has said it will continue with the rollout...
A regional corner of Africa is a hotspot for cases of HIV, tuberculosis and malaria, prompting researchers to call for targeted health support rather than a national response. The new research, published in BMJ Global...
About a year passed between COVID-19’s discovery and the creation of a vaccine. Why was malaria so much harder? The World Health Organization (WHO) recommended a broad rollout for a malaria vaccine after a pilot...
Researchers from The Australian National University (ANU) have discovered a vital clue as to why malaria vaccines keep failing, which could potentially change how vaccines for the deadly disease and others are made...
Researchers develop genetically attenuated parasite (GAP) that arrests late in the liver stage of human malaria In an unprecedented first, scientists at Seattle Children’s Research Institute have developed a...
In regions of the world where malaria is endemic, pregnant women who contract the infection face severe health risks as well as complications in their pregnancies. Blood cells infected with malaria-causing Plasmodium...
The malaria vaccine RTS,S provides sustained protection against severe malaria 7 years after immunization, according to extended findings from a phase 3 trial published in The Lancet Infectious Diseases. Initial results...